Update to PPMI Protocol

PPMI?s updated study protocol (version 11.0) allows for subjects enrolled in the Parkinson?s Disease (PD) and Healthy Control cohorts to continue participation in PPMI beyond month 60.  Subjects in these two cohorts consenting to amendment 10 will be followed through month 96 (V15).

Subjects in the PD cohort will continue with annual in person visits through month 96, while subjects in the Healthy Control cohort will complete one additional in person annual visit (at month 84) and two telephone visits (at months 72 and 96).

A new ancillary study has been added, involving the collection of blood samples for the generation of induced pluripotent stem cells (iPSC).  This will be piloted at select sites.